search icon
  • Print
  • ShareThis
  • Text Size
  • Leading Infectious Diseases Experts Honored at IDWeek 2017 for Outstanding Work in Advancing Patient Health


    Barbara Murray, MD, receives accolades for lifetime achievement

    SAN DIEGO – October 4, 2017 – Among the 10 exceptional individuals being honored by the Infectious Diseases Society of America (IDSA) and the IDSA Foundation  at IDWeek 2017 in San Diego is Barbara E. Murray, MD, FIDSA, recipient of the Alexander Fleming Award for lifetime achievement.

    This year’s IDSA Society Awards features two new categories, the D.A. Henderson Award for Outstanding Contributions to Public Health and the IDSA Clinical Practice Innovation Award. IDSA is pleased to recognize the following individuals for excellence in the field of infectious diseases:

    Alexander Fleming Lifetime Achievement Award Recipient Barbara E. Murray, MD, FIDSA: Exploring antimicrobial resistance

    The current chair of IDSA’s Antimicrobial Resistance (AMR) Committee, Dr. Murray has undertaken investigations exploring the science that forms much of the foundation for our current understanding of enterococcal drug resistance and pathogenesis. Her extensive research in enterococcal resistance, genotyping, genomics and virulence factors has established many of the modern therapeutic paradigms for these important pathogens. Dr. Murray has helped characterize new and promising compounds for antibiotic development using a substantial collection of susceptible and resistant organisms that she maintains through guidance to pharmaceutical companies. Dr. Murray is a recipient of a National Institutes of Health (NIH) MERIT Award and her research has been NIH-funded for more than 25 years.

    Dr. Murray is the J. Ralph Meadows Professor in Internal Medicine and director of the Division of Infectious Diseases at the McGovern Medical School at the University of Texas Health Science Center at Houston, where she has been on the faculty since 1980. She has directly sponsored or mentored more than 50 trainees in the field; issued several chapters for text and online books; published more than 300 articles, which have been cited more than 23,000 times; and served on numerous local, national and international committees including the Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee, the NIH Recombinant DNA Advisory Committee – for which she also served as chair – and NIH’s Bacteriology and Mycology Study Section, among others.

    Dr. Murray was president of IDSA from 2013 to 2014 and has served on the IDSA Board of Directors in multiple roles, including as treasurer for six years and as secretary for three years. A current associate editor for Clinical Infectious Diseases, she also served as an editor for Antimicrobial Agents and Chemotherapy for 10 years and is on the editorial boards of several other prominent journals in the field.

    “Dr. Murray’s contributions have been significant and far-reaching, spanning microbial physiology, virulence, antimicrobial resistance and drug development and IDSA is honored to recognize her with this year’s Alexander Fleming Award for Lifetime Achievement,” said William G. Powderly, MD, president of IDSA. “She has had a profound impact on the field, her colleagues, her mentors and public health.”

    Other awards presented during IDWeek 2017 include:

    • The D.A. Henderson Award  for Outstanding Contributions to Public Health is a new award for 2017, named after the late epidemiologist who directed the international effort to eradicate smallpox. The inaugural recipient of this honor is F. Marc LaForce, MD, FIDSA, of New York University and the Serum Institute of India, Ltd. As the director of the Meningitis Vaccine Project from 2001-2012 – a unique partnership between PATH and the World Health Organization and supported by the Bill and Melinda Gates Foundation – Dr. LaForce brought together a vaccine manufacturer in India and other partners across four continents to successfully develop, test, license and introduce a safe and effective conjugate meningococcal vaccine, MenAfriVac, at less than one-tenth of the cost usually required to bring a new vaccine to market. Available at less than 50 cents per dose, the vaccine was provided to more than 320 million young Africans in the 26 countries that make up the continent’s “meningitis belt” by the end of 2016 – preventing an estimated 1.3 million cases of disease, 250,000 cases of disability, and 130,000 deaths.
    • The Oswald Avery Award recognizes outstanding achievement in infectious diseases by a member or fellow of IDSA who is 45 or younger. This year’s recipient is William J. Steinbach, MD, FIDSA, FPIDS, of Duke University, who has quickly become an international leader as an investigator studying the molecular basis and clinical manifestations of invasive fungal infections. In 2006, Dr. Steinbach founded and still directs the International Pediatric Fungal Network, a 55-site global research consortium currently supported by more than $7 million in NIH funding to lead novel treatment and diagnostic clinical studies in pediatric invasive fungal disease.
    • The Society Citation Award is given in recognition of exemplary contribution to IDSA, outstanding discovery in the field of infectious diseases, or a lifetime of outstanding achievement in a given area – whether research, clinical investigation or clinical practice. This year awards go to:

    Wendy S. Armstrong, MD, FIDSA – Currently chair of the HIV Medicine Association (HIVMA), professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine and medical director of one of the largest urban HIV/AIDS clinics in the country, Dr. Armstrong’s research and practice have focused on HIV and health disparities. Her vast contributions to move the ID specialty forward include serving as vice chair of education and integration at Emory, where she has led one of the nation’s premier ID fellowship training programs as director since 2008; as chair of IDSA’s ID Training Program Directors Committee from 2013 to 2016 and as chair of the Society’s Task Force on ID Fellowship Recruitment since 2015, where she has spearheaded multiple initiatives focused on improving fellowship education, including the transition to an “all in” residency match for the 2016 cycle, which increased the percentage of ID fellowship program slots filled as well as the number of total programs filled.

    Patrick Joseph, MD, FIDSA, FSHEA – Associate clinical professor of medicine at the University of California, San Francisco (UCSF) and medical director of four molecular diagnostic laboratories in northern California, Dr. Joseph’s activities and leadership in the field of diagnostic laboratory medicine have significantly improved the standards in many diagnostic laboratories in the western United States. Named one of America’s Top Physicians and a Best Physician in America multiple times, he continually mentors ID fellows and residents at UCSF while volunteering as a faculty member, maintaining an active private practice, and conducting other extensive work in the field.

    Dean L. Winslow, MD, FIDSA – Vice chair of the Department of Medicine and a professor of medicine in the Division of Hospital Medicine and the Division of Infectious Diseases and Geographic Medicine at Stanford University, Dr. Winslow is a decorated military veteran and longtime champion for patients with HIV and victims of war and disaster. From 2003 to 2011, he deployed to Iraq and Afghanistan six times in support of combat operations and has, since 2006, arranged for medical care, transportation and housing in the United States for more than 20 Iraqi children and adults with complicated medical conditions for which surgical care was not available in Iraq. Among his many accomplishments, Dr. Winslow started Delaware’s first multidisciplinary clinic for HIV-infected patients in 1985, coordinated military public health and force protection in Louisiana after Hurricane Katrina, and has designed and directed several groundbreaking clinical studies and trials leading to FDA-approved therapies and diagnostic devices to improve the treatment and prevention of HIV/AIDS.

    • The Watanakunakorn Clinician Award honors the memory of Dr. Chatrchai Watanakunakorn and is given by the IDSA Foundation to an IDSA member or fellow in recognition of outstanding achievement in the clinical practice of infectious diseases. This year’s awardee is Douglas R. Osmon, MD, MPH, FIDSA, of the Mayo Clinic, whose passion for clinical care has earned him international recognition and greatly advanced the treatment of musculoskeletal infections. The Orthopedic Infectious Diseases Practice he developed and leads at Mayo as chair, which recognizes the necessary link between ID and surgical specialists in caring for patients with orthopedic infections, has set the bar for many other institutions.
    • The Walter E. Stamm Mentor Award, which honors late past-president Walter E. Stamm, MD, is presented to an IDSA member or fellow who has been exceptional in guiding professional growth of infectious diseases professionals. This year’s winner is Stephen B. Calderwood, MD, FIDSA of Massachusetts General Hospital. An exceptional clinician, teacher and researcher, Dr. Calderwood has made the career development of others a central goal of his collaborative research activities, encouraging his mentees to develop into independent physician-scientists and mentors themselves.
    • The Clinical Teacher Award honors a career dedicated to excellence in teaching fellows, residents or medical students, and motivating them to teach the next generation. This year’s honoree is Michael J. Barza, MD, FIDSA, of Tufts University and Medical Center, who has been a major influence on scores of medical students, residents, and infectious disease fellows for the past 45 years. In one telling example of his impact, after Dr. Barza become director of the internal medicine training program at Carney Hospital, the percentage of initial test takers passing their American Board of Internal Medicine examination rose from 70 percent to 100 percent over a four-year period. Many current division chiefs, deans, professors, and other accomplished leaders in the field cite Dr. Barza as a role model in their own careers.
    • The Clinical Practice Innovation Award is a new award for 2017 recognizing an IDSA member who devotes a majority of her or his time to patient care and who has significantly advanced the clinical practice of infectious diseases within the last five years. The inaugural honoree, Kavita P. Bhavan, MD, MHS, FIDSA, of Parkland Hospital, Dallas, is an expert in outpatient parenteral antimicrobial therapy (OPAT). Her innovative multidisciplinary program, which she began in 2009, has brought OPAT to uninsured patients by offering them the option to be taught to self-administer intravenous antibiotics with weekly in-clinic follow up. In the program’s first four years, clinical outcomes for these patients were similar to or better than those for provider-administered methods. Additionally, hospital readmission rates were reduced by 47 percent and more than 27,000 hospital bed days were saved at an estimated cost savings of approximately $40 million, with high patient satisfaction rates. The program’s approach is now being replicated across the country.

    “On behalf of the entire IDSA, I am truly pleased to acknowledge the outstanding work that these inspiring individuals have done and continue to do,” said Dr. Powderly. “From doing groundbreaking research, to providing dedicated practice and mentorship, to heading innovative programs, they are saving lives and moving the field forward. We hope these awards will show our appreciation and inspire the next generation of leaders.”

    For full awards descriptions, recipient biographies and information about other awards given to Society members this year, please visit The Society’s annual meeting, IDWeek 2017 takes place Oct. 4-8 at the San Diego Convention Center. To learn more, visit

    # # #  

    About the Infectious Diseases Society of America

    The Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, prevention, and patient care. The Society, which has more than

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site